Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance

M. Bužga, M. Evžen, K. Pavel, K. Tomáš, Z. Vladislava, Z. Pavel, Z. Svagera,

. 2014 ; 24 (6) : 909-15.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15032065
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2010-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem
Public Health Database (ProQuest) od 1997-02-01 do Před 1 rokem

Odkazy

PubMed 24488758
DOI 10.1007/s11695-014-1191-4
Knihovny.cz E-zdroje

BACKGROUND: The prevalence of obesity continues to increase worldwide. Because obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. Although various treatments are currently available, many are not efficacious in the long term. Therefore, additional medical treatment options for morbidly obese individuals must be explored. In this study, we examined the effects of the intragastric balloon MedSil on anthropometric measures and hormones associated with lipid and energy metabolism. METHODS: Twenty-two obese patients underwent insertion of the intragastric balloon MedSil following a clinical exam, body composition scan, and collection of blood samples. Six months following implantation of the balloon, additional anthropometric and serological measures were taken. RESULTS: Six months following insertion of the MedSil balloon, we observed significant decreases in body weight, body mass index, and fat mass. Compared with baseline levels, ghrelin serum levels were increased significantly, while leptin, FGF21, and glycated hemoglobin levels significantly decreased, 6 months after balloon insertion. CONCLUSIONS: The MedSil intragastric balloon is a safe and effective treatment for morbid obesity, with positive effects on anthropometric measures and lipid metabolism.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15032065
003      
CZ-PrNML
005      
20151014103456.0
007      
ta
008      
151005s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11695-014-1191-4 $2 doi
035    __
$a (PubMed)24488758
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bužga, Marek $u Department of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic, marek.buzga@osu.cz.
245    10
$a Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance / $c M. Bužga, M. Evžen, K. Pavel, K. Tomáš, Z. Vladislava, Z. Pavel, Z. Svagera,
520    9_
$a BACKGROUND: The prevalence of obesity continues to increase worldwide. Because obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. Although various treatments are currently available, many are not efficacious in the long term. Therefore, additional medical treatment options for morbidly obese individuals must be explored. In this study, we examined the effects of the intragastric balloon MedSil on anthropometric measures and hormones associated with lipid and energy metabolism. METHODS: Twenty-two obese patients underwent insertion of the intragastric balloon MedSil following a clinical exam, body composition scan, and collection of blood samples. Six months following implantation of the balloon, additional anthropometric and serological measures were taken. RESULTS: Six months following insertion of the MedSil balloon, we observed significant decreases in body weight, body mass index, and fat mass. Compared with baseline levels, ghrelin serum levels were increased significantly, while leptin, FGF21, and glycated hemoglobin levels significantly decreased, 6 months after balloon insertion. CONCLUSIONS: The MedSil intragastric balloon is a safe and effective treatment for morbid obesity, with positive effects on anthropometric measures and lipid metabolism.
650    _2
$a adipokiny $x krev $7 D054392
650    _2
$a dospělí $7 D000328
650    _2
$a angiopoetiny $x krev $7 D042682
650    _2
$a složení těla $7 D001823
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a energetický metabolismus $x fyziologie $7 D004734
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblastové růstové faktory $x krev $7 D005346
650    _2
$a následné studie $7 D005500
650    12
$a žaludeční balónek $7 D015905
650    _2
$a ghrelin $x krev $7 D054439
650    _2
$a lidé $7 D006801
650    _2
$a metabolismus lipidů $x fyziologie $7 D050356
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a morbidní obezita $x krev $x chirurgie $7 D009767
650    _2
$a výsledek terapie $7 D016896
650    _2
$a hmotnostní úbytek $x fyziologie $7 D015431
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Evžen, Machytka
700    1_
$a Pavel, Klvaňa
700    1_
$a Tomáš, Kupka
700    1_
$a Vladislava, Zavadilová
700    1_
$a Pavel, Zonča
700    1_
$a Svagera, Zdeněk
773    0_
$w MED00180469 $t Obesity surgery $x 1708-0428 $g Roč. 24, č. 6 (2014), s. 909-15
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24488758 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151014103646 $b ABA008
999    __
$a ok $b bmc $g 1092941 $s 915191
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 24 $c 6 $d 909-15 $i 1708-0428 $m Obesity surgery $n Obes Surg $x MED00180469
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Možnosti archivace